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Background: Xanthophyllomyces dendrorhous is a basidiomycetous yeast that is relevant to biotechnology, as it can
synthesize the carotenoid astaxanthin. However, the astaxanthin levels produced by wild-type strains are low.
Although different approaches for promoting increased astaxanthin production have been attempted, no
commercially competitive results have been obtained thus far. A promising alternative to facilitate the production
of carotenoids in this yeast involves the use of genetic modification. However, a major limitation is the few
available molecular tools to manipulate X. dendrorhous.
Results: In this work, the DNA assembler methodology that was previously described in Saccharomyces cerevisiae
was successfully applied to assemble DNA fragments in vivo and integrate these fragments into the genome of
X. dendrorhous by homologous recombination in only one transformation event. Using this method, the gene
encoding astaxanthin synthase (crtS) was overexpressed in X. dendrorhous and a higher level of astaxanthin was
produced.
Conclusions: This methodology could be used to easily and rapidly overexpress individual genes or combinations
of genes simultaneously in X. dendrorhous, eliminating numerous steps involved in conventional cloning methods.
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Xanthophyllomyces dendrorhous is a basidiomycetous yeast
with potential in the biotechnology industry as it is
able to synthesize carotenoids, particularly astaxanthin.
Carotenoids are natural yellow, orange, or red pigments,
and more than 700 different carotenoid chemical struc-
tures have been described to date [1]. Animals are unable
to synthesize these pigments de novo and can only obtain
them in their diet. These pigments are currently used as
food colorants and have received attention for their ability
to alleviate chronic diseases due to their antioxidant prop-
erties, which can mitigate the damaging effects of oxi-
dative stress induced by reactive oxygen species (ROS)
[2]. Among carotenoids, astaxanthin (3,3′-dihydroxy-β,* Correspondence: jalcainog@u.uchile.cl
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reproduction in any medium, provided the orβ-carotene-4-4′-dione) is notable based on its antioxidant
properties, which are greater than those of beta-carotene
or even alpha-tocopherol [3], and the application of asta-
xanthin in the pharmaceutical and cosmetic industries has
recently been explored [4]. Astaxanthin has also been
widely used in the aquaculture industry as a colorant for
cultured salmonids to achieve the flesh color that is pre-
ferred by consumers. In addition, astaxanthin is an essen-
tial nutritional component for proper fish growth and
reproduction, making this compound a significant factor
in aquaculture production costs [4].
X. dendrorhous is one of the few microorganisms that
produces astaxanthin. However, the production of this
pigment by wild-type strains is too low (200–400 μg per g
of dry yeast) to provide a natural source that is eco-
nomically competitive with chemical synthesis of this
pigment. Therefore, many efforts have attempted to im-
prove the astaxanthin production from X. dendrorhous,ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cose concentration [5,6], oxygen levels [6,7], pH [8,9],
carbon/nitrogen ratio [10], and light intensities [11],
in addition to classic random mutagenesis methods
[12-15]. A promising alternative to increase the asta-
xanthin yield in this yeast is to overexpress the genes in-
volved in carotenoid synthesis (Figure 1) for which
several attempts have been performed (For a review see:
[16]). A small increase in the amount of total caroten-
oids was obtained by overexpressing the gene encoding
phytoene synthase-lycopene cyclase (crtYB) by integrating
multiple copies of this gene into the ribosomal DNA
[17]. However, this increase was mainly due to increased
synthesis of beta-carotene and echinenone, while the
astaxanthin content was slightly reduced (or unaffected).
In another experiment in which the gene encoding
phytoene desaturase (crtI) was overexpressed, the overallFigure 1 Diagram of the astaxanthin biosynthetic pathway in X. dend
proposed by [21] and [22]. Metabolite abbreviations: IPP (isopentenyl pyrop
pyrophosphate), FPP (farnesyl pyrophosphate), GGPP (geranylgeranyl pyrop
The names of the genes controlling each step are written in red: idi (IPP-iso
(PBS, phytoene-β-carotene synthase), crtI (PDS, phytoene desaturase), crtS (carotenoid production decreased including a 50% re-
duction in the astaxanthin fraction [17]. Similarly, the
overexpression of the gene encoding isopentenyl pyro-
phosphate isomerase (idi) led to a decrease in the amount
of total carotenoids [18]. In another work attempting to
promote metabolite flow towards carotenoid biosynthesis,
the cDNA encoding the geranylgeranyl pyrophosphate
synthase gene (crtE) was overexpressed, resulting in a
strain with slightly higher carotenoid levels, although the
astaxanthin levels were not increased [19]. However, the
simultaneous insertion of extra copies of the crtYB and
crtS (which encodes the astaxanthin synthase) genes in an
astaxanthin-overproducing strain obtained by random
mutagenesis resulted in transformants with an even higher
astaxanthin content [20]. Therefore, the overexpression of
a single gene is not enough to significantly increase the
astaxanthin level in X. dendrorhous, and overexpression ofrorhous. The astaxanthin biosynthesis pathway in X. dendrorhous
hosphate), DMAPP (dimethylallyl pyrophosphate), GPP (geranyl
hosphate) and HDCO (3-hydroxy-3′,4′-didehydro-β,ψ-carotene-4-one).
merase), crtE (geranylgeranyl pyrophosphate synthase), crtYB
astaxanthin synthase) and crtR (cytochrome P450 reductase).
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provide better results.
One of the major limitations in the genetic manipula-
tion of X. dendrorhous is the limited number of molecu-
lar tools available to transform and engineer this yeast.
Recently, an in vivo method for DNA fragment assembly
and yeast transformation, DNA assembler, was reported
[23]. With this technique, numerous DNA fragments
are assembled in vivo via homologous recombination
at their ends following a single transformation event,
allowing the incorporation of an entire heterologous bio-
chemical pathway in Saccharomyces cerevisiae. As the X.
dendrorhous homologous recombination machinery has
previously been successfully exploited for the develop-
ment of transformation strategies and gene function
analysis [17,24-27], in this work, we adapted the DNA
assembler methodology to overexpress the gene en-
coding astaxanthin synthase (crtS) that catalyzes the for-
mation of astaxanthin from beta-carotene [28,29] in X.
dendrorhous.Results
In vivo assembly and integration of DNA fragments into
the genome of X. dendrorhous
To evaluate the feasibility of assembling DNA fragments
in vivo in X. dendrorhous, a DNA cassette containing
only the gene that confers resistance to hygromycin B
[30] was integrated in the genome of the wild-type X.
dendrorhous strain UCD 67–385. A 1,260 bp locus called
DHS3 [GenBank: JN835289.1] was chosen as one of the
potential target site, which is located at 2,110 bp down-
stream of the X. dendrorhous HIS3 gene. This region is
transcribed and encodes an uncharacterized gene prod-
uct, so we expected that its interruption would not dras-
tically affect the physiology of the yeast.
Three DNA fragments (454 bp DHS3 “up” for upstream,
1,817 bp hygromycin B resistance cassette and 460 bp
DHS3 “down” for downstream) were prepared as illus-
trated in Figure 2A. First, each fragment was individually
PCR amplified with a set of primers designed to make the
5′ end of the fragment overlap the 3′ end of the preceding
DNA fragment. In this way, the hygromycin B resistance
cassette overlaps the two flanking DNA fragments tar-
geting the DHS3 locus. The overlapping region contained
approximately 100 bp of sequence homology between
fragments to allow in vivo homologous recombination be-
tween them. A diploid X. dendrorhous wild-type strain
[31] was co-transformed with the three DNA fragments
by electroporation. Assembly of these fragments and their
integration into the genome was accomplished, as nine
hygromycin B-resistant transformants were obtained. PCR
analyses confirmed that all of them contained the resist-
ance cassette at the expected integration target. However,as the starting strain UCD 67–385 is diploid [31], a wild-
type DHS3 allele was still detected in the resulting
transformants, indicating that they were heterozygous at
this locus. For this reason, one of the transformants was
randomly chosen (named Xd_1H, for one hygromycin-
resistance cassette copy) to obtain the homozygous strain
Xd_2H (2H for two copies of the hygromycin-resistance
cassette) using the double recombinant method (DRM)
[30] (Figure 2A). Panel B of Figure 2 shows the amplicons
obtained from genomic PCR confirming the integration of
the hygromycin B resistance cassette into the expected
locus in strains Xd_1H (DHS3/dhs3::hph) and Xd_2H
(dhs3::hph/dhs3::hph). To the naked eye, the color of the het-
erozygous and homozygous strains is identical to the wild-
type strain and both strains are able to grow in minimal
medium (Figure 2C). Total carotenoids were quantified
and no significant differences were detected between the
transformants and the wild-type strain (data not shown).
Thus, the interruption of the DHS3 locus did not cause
auxotrophy or greatly affected the carotenogenesis in this
yeast.
To confirm that this transformation methodology is
effective for other integration targets, the resistance cas-
sette was successfully integrated into two other genomic
loci. However, the color phenotype of the transformants
was different from the parental strain (data not shown).Increase of crtS gene dose
Next, we used the above methodology to increase the crtS
gene dose. A crtS expression cassette was constructed by
OE-PCR (overlap extension- PCR) and cloned into plas-
mid pBluescript SK-, resulting in the plasmid pBS-PTEF-
crtS-Tact. This cassette was integrated in the DHS3 locus,
as its interruption did not cause auxotrophy or greatly af-
fected the carotenogenesis in this yeast. Four DNA frag-
ments (the hygromycin B-resistance selection marker, the
crtS gene expression cassettes, and the DHS3 locus “up”
and “down” targeting fragments) were individually PCR
amplified with primers allowing 50 to 100 bp of overlap
between adjacent fragments, and then these fragments
were used to co-transform X. dendrorhous by electro-
poration (Figure 3). Four hygromycin B-resistant colonies
were obtained. All had the crtS gene expression cassettes
at the expected locus, as confirmed by PCR analyses with
a comprehensive set of primers. One of these four colonies
was randomly selected, named strain Xd_1H1S (DHS3/
dhs3::hph+crtS, one additional crtS gene copy) and subjected
to DRM to result in a homozygous strain, Xd_2H2S
(dhs3::hph+crtS/dhs3::hph+crtS). The PCR amplification con-
firmed the insertion of the hygromycin B resistance and
crtS expression cassettes at the DHS3 locus in the hetero-
zygous and homozygous transformants are shown in
Figure 4.
Figure 2 Assembly and integration of the hygromycin B resistance cassette into the genome of X. dendrorhous by DNA assembler.
A) Three DNA fragments, DHS3 “up”, hph expression cassette (composed by EF-1α promoter, hph gene and gpd terminator) and DHS3 “down”
were amplified by PCR to direct the integration of the hygromycin B cassette into the DHS3 locus of the X. dendrorhous genome. Then, they were
co-transformed, assembled (by recombination at their overlapping ends) and integrated into the X. dendrorhous genome. The arrows represent
the primers used and the black crosses represent the in vivo homologous recombination event. By this way, the heterozygous strain was
obtained, which was submitted to the double recombinant method (DRM) to obtain the homozygous strain. B) Evaluation of the hygromycin
B cassette integration by PCR of strains Xd_1H (1H, one hygromycin B cassette copy), Xd_2H (2H, two hygromycin B cassette copies) and parental
UCD 67–385 (WT), and control without DNA (−). A scheme representing the primer sets (in arrows and numbers according to Additional file 1:
Table S1) that were used and the DNA target are included under each gel photograph. M: Molecular marker, lambda DNA digested with HindIII.
C) Color phenotype of strains Xd_1H (1H), Xd_2H (2H) and parental UCD 67–385 (WT) grown on an MMV agar plate.
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effectively leads to an increase in the crtS mRNA levels,
RT-qPCR analysis was performed for the wild-type, het-
erozygous and homozygous transformants grown under
the same conditions. Total RNA was extracted after 50 h
of culture (late exponential phase of growth) of each strain
as it was observed that the crtS mRNA level reaches its
maximum level at this stage [32,33]. The relative crtS ex-
pression was normalized to the expression of the actin
gene [34], and RT-qPCR analysis revealed that the expres-
sion of the crtS gene was increased approximately three
fold in the Xd_2H2S strain with respect to the wild-type
strain (UCD-67-385) at this same growth stage (Figure 5).
Carotenoid production
To the naked eye, different pigmentation phenotypes
among the wild-type, Xd_1H1S and Xd_2H2S strains
could be noted. To confirm this observation, thecarotenoid content and composition of these strains
were analyzed. Total carotenoids were extracted from
cell pellets from 24, 50 and 96-h-old yeast cultures (early
exponential, late exponential and late stationary phase of
growth, respectively) grown at 22°C in YM (yeast malt
broth) medium with constant agitation. Carotenoids
were extracted, quantified by absorbance at 465 nm and
their composition was analyzed by RP-HPLC. The re-
sults are summarized in Table 1. Although the total
carotenoid production is not affected in strains that
overexpress crtS, it can be observed that after 50 and
95 h of culture, the percentage of astaxanthin in relation
to the other carotenoids is higher in strains expressing
additional crtS gene copies.
Discussion
There are a limited number of currently available molecu-
lar tools to manipulate and transform X. dendrorhous.
Figure 3 Assembly and integration of hygromycin B resistance and crtS gene expression cassettes into the DHS3 locus of
X. dendrorhous by DNA assembler. Four DNA fragments: DHS3 “up”, hph expression cassette (composed by EF-1α promoter, hph gene and gpd
terminator), crtS gene expression cassette (composed by EF-1α promoter, crtS gene and actin transcription terminator) and DHS3 “down” were
amplified by PCR to direct the integration of exogenous genes into the DHS3 locus of the X. dendrorhous genome. Arrows represent the primers
used (Additional file 1: Table S1).
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required the construction of a plasmid for transformation
[17,25-27], which involves several conventional steps of se-
quential cloning such as DNA amplification, endonuclease
digestion, in vitro ligation and transformation. If the num-
ber of expression cassettes to incorporate in a host is in-
creased, these processes will be time consuming and will
depend on the availability of restriction sites in the cloning
vector. In contrast, the DNA assembler method requires
only DNA fragments with homologous ends. We find
that this methodology works in X. dendrorhous as we
transformed this yeast with three DNA fragments toFigure 4 PCR-based analysis of the crtS expression cassette and hygr
X. dendrorhous. PCR analyses of Xd_1H1S (1S, one additional crtS gene co
67–385 (WT) strains, and the negative control without DNA (−). A scheme
according to Additional file 1: Table S1) and the DNA target are under each
M: Molecular marker, lambda DNA digested with HindIII.integrate a hygromycin B resistance cassette into its gen-
ome. We also increased the number of crtS gene copies in
this yeast by transforming it with four DNA fragments to
be assembled (5,098 kb in total) and integrated in the yeast
genome. We conclude that this methodology can be
employed to engineer X. dendrorhous to interrupt or in-
crease gene copy number of several combinations of genes
in only one transformation event.
In previous studies attempting to overexpress genes in
X. dendrorhous, expression cassettes were integrated into
ribosomal DNA (rDNA) [17-20]. There are approxi-
mately 60 rDNA copies in X. dendrorhous [24], whichomycin B resistance cassette integration into the genome of
py), Xd_2H2S (2S, two additional crtS gene copies), and parental UCD
representing the primers sets that were used (in arrows and numbers
gel photograph. The scheme shading is in accordance with Figure 3.
Figure 5 RT-qPCR expression analysis of crtS in the wild-type
strain and crtS-overexpressing transformants. The crtS transcript
level was normalized to the actin mRNA and was determined from RNA
extracted after 50 h of culture in YM medium from the parental wild-
type UCD 67–385 (WT), the heterozygous Xd_1H1S (DHS3/dhs3::hph+crtS)
and homozygous Xd_2H2S (dhs3::hph+crtS/dhs3::hph+crtS) strains. Values
are the mean ± standard error of at least three independent cultures.
(*P≤ 0.05; Student’s t test).
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into the genome. However, due to the tandem repeats in
this region, the resulting strains are typically unstable as
the integrated genes may be lost by homologous recom-
bination. Additionally, the use of this region makes it
difficult to evaluate the effect of gene dose on the pro-
duction of carotenoids, as it is difficult to quantify the
number of integrated cassette copies. For these reasons,
we excluded the rDNA region as a target site for integra-
tion and focused on integration and resultant target site
disruption in a locus that does not strongly modify the
yeast physiology. From the analyzed targets, the disrup-
tion of locus DHS3 fulfilled this requirement, so it was
chosen to integrate the additional crtS gene copies.
In this work, we studied the effect of altering the meta-
bolic flux between beta-carotene and astaxanthin by in-
creasing the crtS gene dose. Although the total carotenoid
content in strains with one or two additional crtS gene
copies was not substantially modified (Table 1), an in-
creased proportion of astaxanthin relative to the total ca-
rotenoid content was obtained in the strain with two
additional crtS gene copies compared to the wild-type
strain. Astaxanthin represented 96% versus 68% of the ca-
rotenoids in these strains after 96 h of culture. In addition,
reduced proportions of beta-carotene and intermediate
xanthophylls formed during the synthesis of astaxanthin
from beta-carotene such as echinenone, hydroxyechine-
none, canthaxanthin and phoenicoxanthin. These observa-
tions suggest that astaxanthin synthesis is limited by the
amount of astaxanthin synthase substrate, beta-carotene.
Thus, to achieve a significantly higher level of astaxanthin
production, it is also necessary to increase the synthesis ofbeta-carotene. In agreement with this assumption, it has
been observed that the overexpression of the crtYB gene
in X. dendrorhous resulted in increased beta-carotene
production [17] and recently, the simultaneous overex-
pression of the crtYB and crtS genes in a X. dendrorhous
strain created via random mutagenesis that already over-
produced astaxanthin resulted in a higher astaxanthin
content compared to the parental strain (5,300 ppm) [20].
The methodology described in this work should be a help-
ful tool to evaluate the consequences of overexpressing
different combinations of genes involved in carotenoid
production in X. dendrorhous.
Although beta-carotene was almost completely exhausted
in the transformant strain that overexpressed crtS, phoe-
nicoxanthin, the xanthophyll precursor to astaxanthin, was
still present, although its proportion was reduced from 15%
to 6% after 96 h of culture in the wild-type and in the
Xd_2H2S strains, respectively. As astaxanthin synthase is a
cytochrome P450 enzyme, it may also be necessary to in-
crease the cytochrome P450 reductase [25] gene dose to
enhance the activity of this enzyme.
The DNA assembler methodology that has been effect-
ive and successful in X. dendrorhous in this study should
be useful to overexpress several genes simultaneously to
favor the synthesis of carotenoid precursors such as
geranylgeranyl pyrophosphate or genes involved in the
mevalonate pathway [35] in combination with carote-
nogenic genes. Thus, using different promoters in the con-
struction of the gene expression cassettes, it should be
possible to increase and modulate the production of carot-
enoids in X. dendrorhous.
Conclusions
The DNA assembler method is a successful technique to
transform X. dendrorhous. This technique allowed an in-
crease in the crtS gene copy number in the X. dendrorhous
genome. The overexpression of this gene did not signifi-
cantly change the total carotenoid production, but there
was an increase in the astaxanthin fraction of carotenoids.
As DNA assembler requires only DNA fragments with
homologous ends, this technique could be useful to quickly
and easily overexpress several genes simultaneously in X.
dendrorhous, saving numerous steps involved in conven-
tional cloning methods.Methods
The experiments performed in this work were approved
by the Facultad de Ciencias – Universidad de Chile, Eth-
ics Committee.
Microorganisms, plasmids, media, and enzymes
The strains and plasmids that were used and built in this
work are listed in Table 2. The wild type X. dendrorhous
Table 1 Carotenoids in wild-type and transformant strains in ppm (μg per g of dry yeast)
X. dendrorhous strain [ppm (%)]
UCD 67–385 Xd_1H1S Xd_2H2S
(DHS3/DHS3) (DHS3/dhs3::hph+crtS) (dhs3::hph+crtS/dhs3::hph+crtS)
Cultivation time (h) 25 50 96 25 50 96 25 50 96
Carotenoid:


















(100) (100) (100) (100) (100) (100) (100) (100) (100)
Beta-carotene ND 4.37 ± 1.25 6.90 ± 0.57 ND 7.4 ± 0.01 3.93 ± 0.08 ND 2.36 ± 0.29 0.72 ± 0.22
(13) (4) (12) (2) (3) (1)
Equinenone† ND 1.36 ± 0.31 7.01 ± 0.46 ND 2.84 ± 0.01 3.84 ± 0.05 ND 0.54 ± 0.32 0.88 ± 0.03
(4) (4) (4) (2) (1) (1)
OH-equinenone† ND 4.65 ± 0.38 11.47 ± 1.10 ND 5.79 ± 0.01 7.29 ± 0.04 ND 8.85 ± 0.31 1.06 ± 0.16
(14) (6) (9) (4) (10) (1)
Cantaxanthin† ND 0. 46 ± 0.12 2.24 ± 0.90 ND 0.73 ± 0 1.41 ± 0.05 ND 0.39 ± 0.12 0.83 ± 0.21
(1) (1) (1) (1) (1) (1)
Phoenicoxanthin† 0.46 ± 0.39 3.99 ± 0.37 28.41 ± 3.53 0.5 ± 0.41 6.65 ± 0.01 15.93 ± 0.01 ND 5.50 ± 0.41 11.08 ± 0.07
(2) (12) (15) (3) (10) (8) (6) (6)
Astaxanthin† 21.97 ± 0.62 18.81 ± 1.77 128.04 ± 5.06 13.85 ± 0.41 38.05 ± 0.04 154.13 ± 0.09 12.98 ± 0 65.84 ± 0.81 179.21 ± 0.52
(97) (55) (68) (97) (59) (82) (100) (78) (96)
Lycopene ND ND ND ND ND ND ND ND 0.51 ± 0.15
(1)
Neurosporene ND 0.10 ± 0.04 ND ND 0.54 ± 0.01 ND ND ND ND
(0) (1)
Torulene* ND 0.07 ± 0.04 ND ND 0.206 ± 0.01 ND ND ND 0.45 ± 0.03
(0) (1) (1)
OH-keto-torulene†* ND 0.47 ± 0.20 0.76 ± 0.52 ND 1.72 ± 0.02 1.85 ± 0.02 ND 0.95 ± 0.24 1.49 ± 0.26
(1) (1) (2) (1) (1) (1)
ND: Not detected. Table values correspond to the average result from three independent cultures ± standard deviations. Percentage relative to total carotenoids is
indicated in parentheses. †: hydroxy or/and keto carotenoid, *: monocyclic carotenoid.
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tal strain for transformation experiments and E. coli
DH-5α was used as a host for plasmid propagation.
X. dendrorhous strains were grown at 22°C with con-
stant agitation in YM medium (1% glucose, 0.3% yeast ex-
tract, 0.3% malt extract and 0.5% peptone) or minimal
MMV+ 2% glucose medium [36]. Yeast transformant
selection was performed on YM 1.5% agar plates sup-
plemented with 15 μg/ml hygromycin B. E. coli strains
were grown with constant agitation at 37°C in Luria-
Bertani (LB) medium and supplemented with 100 μg/ml
ampicillin for plasmid selection and 80 μg/ml X-gal (5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside) for re-
combinant clone selection [37].
Enzymes were purchased from Promega (Taq DNA pol,
restriction enzymes, M-MLV reverse transcriptase) and
Pfu DNA pol was purchased from Agilent Technologies.DNA amplification
All of the nucleotides used in this work were purchased
from Alpha DNA (Montreal, Canada) or from Integrated
DNA Technologies and are listed in Additional file 1:
Table S1. PCR reactions were performed in a final vol-
ume of 25 μl containing 2 U of Taq DNA pol, 2.5 μl of
10× Taq buffer, 0.5 μl of 10 mM dNTPs, 1 μl of 50 mM
MgCl2, 1 μl of 25 μM of each primer and 10–20 ng of
template DNA. Amplification was performed in a DNA
thermal cycler 2720 (Applied Biosystems) as follows: ini-
tial denaturation at 95°C for 3 min; 35 cycles of denatur-
ation at 94°C for 30 s, annealing at 55°C for 30 s, synthesis
at 72°C for 3 min and a final extension step at 72°C
for 10 min. Samples were kept at 4°C until use. The
amplicons were separated by 0.8% agarose gel electro-
phoresis in TAE buffer containing 0.5 μg/ml ethidium
bromide [37] followed by DNA purification using the
Table 2 Strains and plasmids used and built in this work




DH-5α F- φ80d lacZΔM15Δ (lacZY-argF) U169 deoR recA1 endA1 hsdR17(rk- mk+) phoA supE44l- thi-1 gyrA96 relA1 [37]
X. dendrorhous:
UCD 67-385 ATCC 24230, wild-type. Diploid strain [31]. ATCC
Xd_1H (DHS3/dhs3::hph). Heterozygote transformant derived from UCD 67–385 containing an allele of the DHS3 locus with
a deletion and a hygromycin B resistance cassette.
This work
Xd_2H (dhs3::hph/dhs3::hph). Homozygote transformant derived from Xd_1H by DRM [30] with a deletion and a hygromycin
B resistance cassette in both alleles of the DHS3 locus.
This work
Xd_1H1S (DHS3/dhs3::hph+crtS). Heterozygote transformant derived from UCD 67–385 with a deletion in one DHS3 allele and
bearing the hygromycin B resistance cassette and the crtS gene expression cassette.
This work
Xd_2H2S (dhs3::hph+crtS/dhs3::hph+crtS). Homozygote transformant derived from Xd_1H1S by DRM with a deletion in both DHS3





ColE1 ori; AmpR; cloning vector for blue-white selection Stratagene
pMN-hph pBS containing a cassette of 1.8 kb bearing the resistance Hygromycin B (hph) gene under EF-1 α promoter and
gpd transcription terminator of X. dendrorhous in its EcoRV site.
[30]
pXd_Ex_crtS pBS containing the cDNA encoding the X. dendrorhous crtS gene in its EcoRV site. [26]
pBS-PTEF-crtS-
Tact
pBS containing a 2,367 bp cassette bearing the cDNA encoding the X. dendrorhous crtS gene under EF-1α
promoter and the actin transcription terminator from X. dendrorhous in the EcoRV site.
This work
ATCC: American Type Culture Collection.
DHS3 [GenBank: JN849376.1]: locus downstream of the X. dendrorhous HIS3 gene [GenBank: JN849374.1].
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cassette construction.
To reduce the error rate in DNA amplification for
Overlap Extension-PCR (OE-PCR, [39] and DNA frag-
ment amplification for X. dendrorhous transformation,
Pfu DNA pol was used instead of Taq DNA pol follow-
ing the manufacturer’s instructions.
Cloning and construction of the crtS gene expression
cassette
The crtS gene expression cassette was constructed by Over-
lap Extension-PCR (OE-PCR) [39] containing 1,674 bp of
the cDNA of the crtS gene [GenBank: DQ002007.1] under
the control of 393 bp of the X. dendrorhous EF-1α pro-
moter [26] and 300 bp of the actin transcription terminator
of [GenBank: X89898.1]. The EF-1α promoter region was
amplified by PCR with primers 1 and 2 (Additional file 1:
Table S1) using pMN-hph as a template (Table 2), and the
actin gene terminator was amplified from UCD 67–385
genomic DNA using primers 5 and 6 (Additional file 1:
Table S1). The crtS cDNA was amplified from pXd_Ex_crtS
(Table 2) with primers 3 and 4 (Additional file 1: Table S1).
First, the promoter region was joined to the crtS cDNA
and then the hybrid product was joined to the actin gene
transcription terminator by OE-PCR. The resulting cassette
was cloned into the EcoRV site of plasmid pBS (pBS-PTEF-
crtS-Tact, Table 2) and was sequenced on both strandsusing a DYEnamic ET Terminator Kit (Amersham Bio-
science) in an ABI 3100 Avant genetic analyzer. DNA
sequences were analyzed with Vector NTI Suite 10
(Informax) and bioinformatics programs available online.
X. dendrorhous transformation
X. dendrorhous transformation was performed by electro-
poration according to [40] and [41]. Electrocompetent
cells were prepared from an exponential culture with
DO600nm = 1.2, cultured in YM medium and electro-
porated using a BioRad Gene Pulser Xcell with PC and CE
modules under the following conditions: 125 mF, 600 Ω,
0.45 kV. The yeast were transformed with 4 μl of a mix-
ture of purified DNA fragments (1 μg of each fragment)
that were amplified by PCR with Pfu DNA pol and
primers with 5′ complementary ends to allow their assem-
bly by homologous recombination. In each transformation
event, in addition to the selection marker and/or the crtS
gene expression cassette, “up” and “down” DNA fragments
were included targeting the insertion into the integration
site. The hygromycin B resistance and crtS gene ex-
pression cassettes were amplified from plasmids pMN-
Hyg and pBS-PTEF-crtS-Tact, respectively, and the “up”
and “down” DNA fragments were amplified from X.
dendrorhous wild-type genomic DNA. Transformant se-
lection was performed on YM 1.5% agar plates sup-
plemented with 15 μg/ml hygromycin B. As strain
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were obtained. To obtain homozygous transformants, the
double recombinant method (DRM) [30] was applied. The
transformant strains were confirmed as X. dendrorhous by
examining the ITS1, 5.8 rRNA gene and ITS2 DNA se-
quences [42,43].
RNA extraction, single strand DNA synthesis and RT-qPCR
To measure the relative crtS gene expression, total RNA
was extracted from 50 h yeast cultures (late exponential
phase of growth) grown at 22°C with constant agitation in
YM medium. The cell pellets from 5 ml culture aliquots
were frozen with liquid nitrogen and stored at −80°C until
use. Total RNA extraction from the cell pellets was
performed by mechanical rupture with 0.5 mm glass beads
(BioSpec) during 10 min of vortexing, followed by the
addition of Tri-Reagent (Ambion). The lysate was incu-
bated for 5 min at room temperature and 200 μl of chloro-
form per ml of Tri-Reagent used was added, mixed, and
centrifuged for 5 min at 4,000 × g. Following this centrifu-
gation, the aqueous phase was recovered. The RNA was
precipitated by adding two volumes of isopropanol and in-
cubating at room temperature for 10 min. The RNA was
washed with 75% ethanol, suspended in RNase-free H2O
and quantified by absorbance determination at 260 nm in
a double beam Shimadzu UV-150-20 spectrophotometer.
The synthesis of cDNA was performed according to
the M-MLV reverse transcriptase (Invitrogen) manufac-
turer’s protocol with 5 μg of total RNA in a final volume
of 11 μl. The determination of the relative crtS gene
expression levels was performed in an Mx3000P quan-
titative PCR system (Stratagene) using 1 μl of the reverse
transcription reaction, 0.25 μM of each primer (Add-
itional file 1: Table S1) and 10 μl of the SensiMix SYBR
Green I (Quantace) kit reagent in a final volume of
20 μl. The obtained Ct values were normalized to the re-
spective value of the actin gene [GenBank: X89898.1]
[44] and expressed using the 2-ΔCT method [45,46].
Carotenoid extraction and RP-HPLC
Carotenoids were extracted from cell pellets from 24, 50
and 96-hours-old yeast cultures (early exponential, late
exponential and late stationary phase of growth, respect-
ively) grown at 22°C with constant agitation in YM
medium using the acetone extraction method [12]. Total
carotenoids were quantified by absorbance at 465 nm
using an absorption coefficient of A1% = 2,100. The ana-
lyses were performed at least in triplicate, and pigments
were normalized relative to the dry weight of the yeast.
Carotenoids were separated by RP-HPLC using a reverse
phase RP-18 LiChroCART 125–4 (Merck) column with
acetonitrile:methanol:isopropanol (85:10:5 v/v) as the
mobile phase under isocratic conditions with a 1 ml/min
flux. The elusion spectra were recovered using a diodearray detector, and carotenoids were identified by their
spectra and retention time according to standards.
Additional file
Additional file 1: Table S1. Primers used in this work.
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